MYB and ovarian carcinoma: Based upon our observation that c-MYB overexpression induces miR-21 and the cisplatin resistance of ovarian cancer cells, and that such condition leads to activation of wnt signaling, we further tested if silencing of c-MYB could have the reverse effects.